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Experimental hookworm infection
and escalating gluten challenges
are associated with increased
microbial richness in celiac subjects
Paul Giacomin1, Martha Zakrzewski2, John Croese3, Xiaopei Su4, Javier Sotillo1,
Leisa McCann3, Severine Navarro1, Makedonka Mitreva5,6, Lutz Krause2,7,
Alex Loukas1,* & Cinzia Cantacessi1,4,*
The intestinal microbiota plays a critical role in the development of the immune system. Recent
investigations have highlighted the potential of helminth therapy for treating a range of
inflammatory disorders, including celiac disease (CeD); however, the mechanisms by which helminths
modulate the immune response of the human host and ameliorate CeD pathology are unknown. In
this study, we investigated the potential role of alterations in the human gut microbiota in helminthmediated suppression of an inflammatory disease. We assessed the qualitative and quantitative
changes in the microbiota of human volunteers with CeD prior to and following infection with human
hookworms, and following challenge with escalating doses of dietary gluten. Experimental hookworm
infection of the trial subjects resulted in maintenance of the composition of the intestinal flora,
even after a moderate gluten challenge. Notably, we observed a significant increase in microbial
species richness over the course of the trial, which could represent a potential mechanism by which
hookworms can regulate gluten-induced inflammation and maintain intestinal immune homeostasis.

The human gut is inhabited by ~1000 species of bacteria (i.e. the gut microbiota) that play essential roles
in human health, including nutrient metabolism, protection against pathogens and regulation of both
innate and adaptive immune responses1-3. The nature and composition of the intestinal microbiota is
subject to a range of factors, including host genetics, immune status, diet and co-infections with extraneous pathogens4. Perturbations in the symbiotic relationship that exists between the commensal microbiota and the host immune system have been associated with a number of chronic inflammatory and
metabolic diseases of the gastrointestinal tract, including obesity, diabetes, inflammatory bowel disease
(IBD) and celiac disease (CeD), disorders that are becoming increasingly prevalent, particularly in the
developed world5-7. For example, both the concentrations of mucosally-associated bacteria and the nature
of the bacterial species are distinct in individuals with IBD, with substantial depletions in Bacteroidetes
and Lachnospiraceae and expansion of populations of Actinobacteria and Proteobacteria8,9. Similarly,
CeD (an autoimmune disorder characterised by an inappropriate immune response to dietary gluten)
is associated with increased populations of Bifidobacterium spp. and Staphylococcus spp. and reductions
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in Bacteroides spp.10. Hence, addressing the microbiological alterations in patients with these chronic
inflammatory disorders may be a viable therapeutic strategy, with some encouraging findings from a
limited number of small studies11-13.
One of the hypotheses as to why allergic and autoimmune diseases of the gastrointestinal tract, such
as food allergy and CeD, are increasing is the change in relative exposure to commensal and pathogenic
organisms as a consequence of urbanization and improved sanitation in the developed world14. It has
been proposed that re-introduction of some of these infectious organisms, and particularly of parasitic
helminths, could lead to novel therapies to treat autoimmune diseases15-22. One of the mechanisms by
which helminths have been proposed to regulate immune homeostasis is via modulation of bacterial
communities in the intestine23-25. However, these studies were performed in animal models of helminth
infection and it is unclear if similar mechanisms operate in humans.
We have recently demonstrated that experimental infection with the human hookworm, Necator
americanus, improved gluten tolerance in CeD subjects22. N. americanus infections were associated with
suppression of pro-inflammatory cytokines and increase of both the frequency of immune-regulatory
cells and cytokines in the gut following gluten challenges19,22,26; however, the mechanism/s by which
hookworms modulate the immune response of their human hosts, thus potentially ameliorating the
symptoms of chronic inflammatory disorders of the intestinal tract, are yet to be fully understood. In
particular, given the role played by gut dysbiosis in the pathogenesis of CeD27, it is possible that the
‘curative’ properties of hookworms are partly associated with the ability of these parasites to induce
qualitative and/or quantitative modifications in the gut microbiota, thus contributing to the restoration of intestinal immune homeostasis. To address this hypothesis, we recently investigated the impact
that experimental infections of healthy CeD subjects (on a gluten-free diet, GFD) with N. americanus
exert on the composition of the gut microbiota and the relative abundance of different microbial species28. No detectable qualitative and quantitative differences were observed between samples prior to and
8 weeks following hookworm infection, thus indicating that the microbial community composition of
each subject remained stable over the relatively short timeframe of the study28. However, the changes in
gut microbiota of hookworm-infected CeD subjects following gluten challenge was not investigated. In
the present study, capitalising on the sampling opportunities provided by our published clinical trial22,
we explore the qualitative and quantitative changes in gut microbiota of CeD subjects prior to and following experimental infection with N. americanus, as well as following the administration of escalating
doses of gluten.

Results

The fecal microbiota of Trial subjects differs from that of active CeD control subjects. Each

of the eight Trial subjects had been on a strict GFD for at least 5 years prior to trial commencement, and
recorded sub-clinical Marsh scores prior to entering the trial22. We first assessed the baseline pre-trial
(T0) composition of the fecal microbiota of the Trial subjects and compared it with that of a cohort of
individuals from the same metropolitan area with active Marsh 3 +  grade CeD (Table S1). Trial subjects displayed a greater abundance of the phylum Bacteroidetes than Control subjects (t-test: p =  0.04;
FDR =  0.12), while Firmicutes were more abundant in the Control subjects (p =  0.07; FDR =  0.12,
Figs 1A and 2). In addition, Tenericutes RF39 were detected in the fecal microbiota of all Control subjects, but only in one Trial subject (ID12; Fig. 2). At the class level, Bacteroidia were more prevalent in
the Trial subjects (p =  0.04; FDR =  0.17), whereas Erysipelotrichi were more abundant in the Control
subjects (p =  0.02; FDR =  0.17), as were Clostridia, although the differences did not reach significance
(p =  0.13; FDR =  0.2, Fig. 1B). Similarly, at genus level, Ruminococcus dominated the fecal microbiota of
the Control subjects (p =  0.001; FDR =  0.02, Fig. 1C), while Lachnospira was more abundant in the Trial
subjects (p =  0.027; FDR =  0.16) (Fig. 1C). Comparison of Kyoto Encyclopedia of Genes and Genomes
(KEGG) functional profiles (predicted by PICRUSt) of Trial subjects pre-trial with those of the Control
subjects displayed differential regulation of 8 biological pathways, with up-regulation of pathways linked
to sugar uptake (i.e. “Multiple sugar transport system permease protein”, KO codes K02026 and K02025;
p <  0.03; FDR =  0.2) in the Control subjects (Figure S1), associated with bacteria within the genus
Ruminococcus (data not shown). Together, these data demonstrated that the microbiota of the healthy
Trial subjects pre-hookworm and pre-gluten challenge was distinct from individuals with active CeD.

Changes in fecal microbiota following hookworm infection and gluten challenge revealed by
targeted gene sequencing. We next aimed to assess whether the nature of the commensal makeup

was altered in the Trial subjects following experimental hookworm infection and subsequent escalating
gluten challenges. All eight subjects were successfully infected with N. americanus, as evidenced by positive detection of hookworm eggs in the feces from weeks 8 to 52 post-infection22. Fecal samples were
collected from each of these subjects 8 weeks after hookworm infection (T8), as well as at defined intervals following sequential challenges with 50 mg gluten/day for 12 weeks (T24), 350 mg gluten/day for 12
weeks (T36) and 3 g gluten/day for 2 weeks (T52). All samples were subjected to 454-based metagenomic
sequencing; however, two Trial subjects did not provide fecal samples at either T52 (subject ID2) or
T36 and T52 (ID12), hence sequence data was not available for these individuals at these time points.
In addition, as the raw sequence data for Trial subject ID10 at T36 consisted of a total of 18 sequences
only, this sample was excluded from subsequent analyses. A total of 346,669 useable reads were assigned
Scientific Reports | 5:13797 | DOI: 10.1038/srep13797
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Figure 1. The fecal microbiota of Trial subjects differs from that of active CeD control subjects.
Differences in the composition of the fecal microbiota of Trial subjects prior to hookworm infection (T0)
and of active celiac disease Control subjects were determined at (A) phylum, (B) class and (C) genus level.
*p <  0.05, **p <  0.01.

Figure 2. Composition of the fecal microbial communities (at phylum level). Microbial composition
of fecal samples from Trial subjects (ID*) prior to and following infection by Necator americanus (T0 and
T8, respectively), as well as following administration of escalating doses of gluten (50 mg/day – T24;
350 mg/day – T36; 3 g/day – T52) as predicted in the analysis of the V1-V3 16S rRNA gene. The
composition of the microbial communities detected in fecal samples from Control subjects with active
celiac disease (C*) is also shown.

to 7,262 Operational Taxonomic Units (OTUs) and 6 bacterial phyla, respectively (data available from
the corresponding author upon request). Consistent with previous investigations, including our own28,
the phyla Bacteroidetes and Firmicutes dominated the intestinal microbiota of all subjects included in the
Scientific Reports | 5:13797 | DOI: 10.1038/srep13797
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Figure 3. Composition of the fecal microbial communities at phylotype level. Microbial composition
of fecal samples from Trial subjects (ID*) prior to and following infection by Necator americanus (T0
and T8, respectively), as well as following administration of escalating doses of gluten (50 mg/day – T24;
350 mg/day – T36; 3 g/day – T52) as predicted in the analysis of the V1-V3 16S rRNA gene. Bubble sizes
reveal the relative abundance (%) of phylotypes (based on 97% sequence identity) in each sample. The
composition of the microbial communities detected in fecal samples from Control subjects with active celiac
disease (C*) is also shown. OTUs listed were present in at least one sample at a relative abundance of ≥ 7%.

Figure 4. Principal coordinates analysis (PCoA) reveals stable composition of fecal microbial
communities over time. The fecal microbiota of Trial subjects prior to and following experimental infection
with Necator americanus, and following administration of escalating doses of gluten was assessed by PCoA.
The composition of the microbial communities detected in fecal samples from Control subjects with active
celiac disease is also shown. Community similarity was calculated using the Jaccard distance measure of the
phylotypes.

study at all time points investigated (Figs 2 and 3), with substantial inter-individual differences observed
at all time points with regard to some of the less abundant phyla such as Proteobacteria, Tenericutes
and Verrucomicrobia (Fig. 2). Further analysis of specific OTUs within the major phyla of Bacteroidetes
and Firmicutes again revealed substantial inter-individual variation at all time points examined (Fig. 3).

Hookworm infection and gluten challenge is associated with increased microbial richness.

Consistent with the results of our previous study28, a Principal Coordinates Analysis (PCoA) of the
fecal microbial communities detected in the Trial subjects showed strong clustering of the samples by
individual rather than infection status and/or exposure to escalating doses of gluten in the two main
dimensions (Fig. 4), thus indicating that the community composition of each subject remained stable
over the course of the trial. Similarly, both Anosim and Redundancy Analysis (RDA) indicated a clear
clustering of samples by individual (p =  0.001 Anosim; p <  0.001 RDA). In the Trial subjects, hookworm
infection and/or exposure to escalating doses of gluten did not impact community structure (p >  0.1
Scientific Reports | 5:13797 | DOI: 10.1038/srep13797
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Figure 5. Hookworm infection and gluten challenge is associated with increased microbial richness.
Pairwise comparisons depicting the overall taxonomic richness of the fecal microbiota of Trial subjects (A)
prior to hookworm infection (T0) and following the administration of escalating doses of gluten (T52), and
(B) post-hookworm infection (T8) and post-gluten challenge (T52), respectively.

Anosim, p >  0.16 RDA), which is indicative of an inter-individual variability and intra-individual stability of the gut microbiota despite hookworm infection and gluten challenge. In line with this observation,
there was no significant difference in relative abundance of any individual OTU identified in the study
(97% sequence identity) across time points (FDR >  0.54 with both t-test and Wilcoxon test). While no
significant difference in Shannon diversity was observed on the global microbial communities over the
whole course of the study (p =  0.91, ANOVA), we detected a significant increase in bacterial species
richness at T52 (following hookworm infection and exposure to 3 g/day of gluten) when compared to
T0 (prior to hookworm infection) (p =  0.033, paired t-test) and at T36 (following hookworm infection
and exposure to 350 mg/day gluten) when compared to T8 (following hookworm infection but prior to
gluten challenge) (Fig. 5) (p =  0.007). Together, these data suggest that hookworm infection supports
maintenance of the composition of the intestinal flora in the presence of escalating gluten challenges,
with concomitant significant increases in microbial species richness.

Discussion

In our recent study22, we showed that experimental infections with N. americanus enabled individuals
with CeD to tolerate escalating challenges with dietary gluten. The biological, immunological and molecular mechanisms underlying this outcome are yet to be fully determined; however, we hypothesized
that an expansion of regulatory T cells, together with reductions in pro-inflammatory effector T cells in
the duodenum, may have been responsible for the restoration of the intestinal homeostasis and, consequently, for the improved gluten tolerance19,22,26. However, other elements within the complex spectrum
of host-parasite interactions may have contributed to this cascade of biological events in the study subjects. Here, we evaluated the impact of hookworm infection and gradual re-introduction of gluten into
the diet on the microbial communities inhabiting the intestine of the same cohort of volunteers who
took part in the clinical study22.
We had hypothesized that experimental hookworm infection, combined with exposure to escalating
doses of gluten, would result in significant quantitative and qualitative fluctuations of the gut microbiota
populations of the volunteers. However, we detected no significant differences in the overall community
structure, Shannon diversity or relative abundance of individual bacterial species over the course of our
study, in accordance with the findings of our previous investigation in which a 8-week, acute hookworm
infection alone did not result in significant alterations of the fecal microbiota28. However, in the present
study, we observed a significantly increased microbial richness (= total number of microbial species present) in fecal samples of Trial subjects collected following hookworm infection and moderate gluten challenge, compared with pre-trial samples. One possible explanation for this discrepancy is that hookworms
may actively contribute to the maintenance of bacterial homeostasis in the gut28 and ‘restore’ homeostasis
(by promoting an increase in microbial richness) when inflammatory responses are triggered (e.g. by the
introduction of gluten in a celiac subject). Alternatively, it is possible that hookworm-induced changes
in microbial species richness can only be detected following the establishment of chronic, rather than
acute, infections28. The latter theory is also substantiated by the results of a recent investigation, in which
a significantly increased species richness was detected in the intestinal microbiota of individuals from
indigenous Malaysian communities naturally infected with gastrointestinal helminths (Trichuris and/or
Scientific Reports | 5:13797 | DOI: 10.1038/srep13797
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hookworms and/or Ascaris sp.) when compared with helminth-free, uninfected subjects from the same
areas29. Similarly, a study using a primate model of chronic idiopathic diarrhea showed that experimental
infections with whipworms were associated with a significant increase of microbial species richness and
evenness (= diversity) which, in turn, had been hypothesized to play a role in the restoration of intestinal
homeostasis and symptomatic improvement24. In our study, the increase in species richness that followed
hookworm infection was not associated with an increase in Shannon diversity (p >  0.05). This finding
may be the result of limited statistical power as direct consequence of our small sample size, which may
also have been responsible for the small (albeit significant) differences in microbial species richness
observed over the course of the study. Nevertheless, a higher species richness of the gut microbiota has
generally been associated with a “healthier” intestinal homeostasis30-32. In particular, a study comparing
the intestinal microbiota of subjects suffering from Crohn’s Disease and Ulcerative Colitis with that of
healthy controls revealed that species richness was significantly higher in the latter30. In addition, the
microbiota isolated from non-inflamed tissue from diseased subjects displayed significantly increased
species richness when compared with that from inflamed biopsy samples from the same individuals30.
Therefore, based on the results of the present and previous studies that associate increased microbial
species richness to infections with helminths29 and the amelioration of inflammation24,30-32, we hypothesize that the therapeutic properties of hookworms may be partly linked to their ability to promote
species richness and restore/maintain microbial (and immune) homeostasis in the gastrointestinal tract28.
However, one limitation of our clinical study22 was the unavailability of a hookworm- or gluten-placebo
cohort; therefore, larger placebo-controlled trials, together with the definition of the enterotype of each
subject33, are necessary to confirm whether hookworms alone, or the gradual reintroduction of dietary
gluten, are involved in modulation of the microbiota.
Three fecal samples from volunteers with active CeD (Control) were included in our study and compared with the pre-trial (T0) samples from the Trial subjects. Quantitative differences in the abundance
of the main phyla were observed between the two groups; in particular, the Firmicutes dominated the
microbiota of the Control subjects with active CeD (albeit this difference was below statistical significance), whereas the Bacteroidetes were more abundant in the healthy Trial subjects. Despite this overall
trend, the genus Lachnospira (a Firmicutes) was more abundant in the Trial subjects (but below statistical significance); Clostridia and Ruminococcus (both within the phylum Firmicutes) dominated the
fecal microbiota of the Control subjects. A shift in the Bacteroidetes to Firmicutes ratio in association
with active CeD has already been documented in a previous study examining the effects of sustained
GFD on the composition of the duodenal microbiota of adult CeD volunteers6,13. Given the recently
described roles of Firmicutes in the metabolism of gluten34, the abundance of bacteria within this phylum
in subjects with active CeD may reflect the dietary habits of these volunteers. In contrast, the abundance of Clostridia and Ruminococcus (at the class and genus level, respectively), in the Control subjects
is in disagreement with previous findings reporting Methylobacterium (class Alphaproteobacteria) and
Mycobacterium (Actinobacteria) as the prevalent genera of bacteria in the gut microbiota of adults with
active CeD6. One possible explanation for this discrepancy is technical, and likely to be associated to
methodological differences between our study and that by Nistal et al.6; indeed, the latter utilized PCR
amplification of the bacterial 16 S rRNA gene, followed by cloning and sequencing of randomly-picked
clones, yielding ~50 sequences per sample. Therefore, in our opinion, the vast difference in sequencing
depth between our study and that by Nistal et al.6 does not warrant direct comparisons of findings.
However, a higher prevalence of Clostridia had been detected in the feces of CeD children with active
disease compared with CeD controls on a strict GFD35. In addition, a recent investigation of the fecal
microbiota of infants at either high- or low- genetic risk of developing CeD (HLA-DQ2 carriers and
non-HLA-DQ2 carriers, respectively) revealed that the former is characterized by significantly higher
proportions of Clostridia27. However, the role of this bacterial group in the progression of CeD is yet to
be ascertained.
In conclusion, the present study has revealed a potential beneficial consequence of hookworm infection in the context of an autoimmune disease, i.e. supporting the maintenance and diversity of commensal flora. Whether hookworm-mediated changes in the microbiota are causal for the improved gluten
tolerance and reduced inflammation in CeD is unknown, but could be examined in greater detail in
an animal model of the disease. It also remains possible that hookworm-induced immunoregulation is
mediated by additional mechanisms, in particular the direct actions of parasite excretory/secretory proteins on immune cells36. Clearly, helminth-based therapies hold promise for a range of autoimmune or
inflammatory conditions, and reversal of the dysbiosis associated with these disorders by tissue-resident
parasites is one potential mechanism that requires further investigation.

Methods

Ethics statement. This study was approved and carried out in strict accordance and compliance with
the National Statement on Ethical Conduct in Research Involving Humans guidelines of the National
Health and Medical Research Council of Australia (NHMRC). The Prince Charles Hospital (Brisbane,
Australia) and James Cook University Human Research Ethics Committees approved the study. Written
informed consent was obtained from all subjects enrolled in the study. This study was registered as a
clinical trial at ClinicalTrials.gov as NCT0067113822.
Scientific Reports | 5:13797 | DOI: 10.1038/srep13797
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Trial design. Eight otherwise healthy volunteers with HLA-DQ2 +  or HLA-DQ8 +  CeD on a strict

GFD (> 5 years) (= Trial subjects) were infected percutaneously with 20 infective third stage larvae of
N. americanus26. Subjects then underwent escalating exposure to dietary gluten (as spaghetti), with a
10–50 mg/day micro-challenge from weeks 12–24, followed by intermittent twice weekly 1 g/day gluten
challenge from weeks 24–36 and a 3 g/day challenge from weeks 48–5022. Prior to experimental infection
(T0), as well as at 8 weeks (T8), 24 weeks (T24), 36 weeks (T36) and 52 weeks (T52) post-infection, individual fecal samples were collected from each subject and stored at –20 °C. In addition, individual fecal
samples from three hookworm-naïve volunteers with active CeD (diagnosed as Marsh grade 3 at the time
of biopsy22) (= Control subjects) were also included for comparative purposes (Table S1).

DNA extraction and 16S rRNA pyrosequencing. Genomic DNA was extracted directly from
each sample using the PowerSoilTM DNA isolation kit (MoBio, USA), according to the manufacturer’s
instructions. The V1-V3 hypervariable region of the 16S gene was PCR amplified using universal primers
described previously28 and sequenced on a 454 GS-FLX Titanium platform (Roche). Forward primers
incorporated GS Titanium adapters as well as a sample-specific barcode sequences. Raw sequence data
have been deposited in the NCBI Sequence Read Archive under accession number SRP059769.
Bioinformatics analyses. Sequence data were processed using the Quantitative Insights Into Microbial

Ecology (QIIME) software suite37. Briefly, after filtering of low-quality reads, all remaining sequences were
de-multiplexed, and chimeric sequences were removed using UCHIME v 3.0.617. Sequences were subsequently clustered into Operational Taxonomic Units (OTUs) on the basis of similarity to known bacterial sequences in the Greengenes database (v13.5; http://greengenes.secondgenome.com/; cut-off: 97%
sequence similarity) using the UCLUST software; then, sequences were assigned to taxonomy using the
Ribosomal Database Project (RDP) Classifier with the confidence level set at 0.8. Statistical analyses and
data mining were conducted using the Calypso software (http://bioinfo.qimr.edu.au/calypso/). Shannon
diversity and rarefied richness (rarefy function in vegan Bioconductor package) were compared by paired
t-test and rarefaction curves. Differences in abundance of individual OTUs were assessed by paired t-test
on square root transformed relative abundance values and Wilcoxon test (Table S2), and p-values were
corrected for multiple testing by false discovery rate (FDR). Anosim (Jaccard distance), redundancy analysis (RDA; including human subject and week as explanatory variables), Principal Coordinates Analysis
(PCoA; Jaccard distance) and rarefaction analyses were run in Calypso with default parameters. Anosim
and RDA were applied on the OTU table using Jaccard distance. RDA was executed including the environment variables infection status and subject ID. Anosim was run separately for infection status and
subject ID. The software PICRUSt38 was then used to predict metagenomic functional content from the
Greengenes-picked OTUs and predict KEGG pathway abundance. Briefly, sequences were clustered into
OTUs using the reference database Greengenes (v13.5). Reference OTUs were normalized by copy number, and PICRUSt metagenome predictions were calculated.
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